[Optimal administration schedules of antineoplastic antibiotics based on their pharmacokinetics, with special reference to bleomycins and anthracyclines]
- PMID: 6191712
[Optimal administration schedules of antineoplastic antibiotics based on their pharmacokinetics, with special reference to bleomycins and anthracyclines]
Abstract
Optimal dose schedule of administration of antitumor antibiotics-bleomycin, adriamycin and aclacinomycin A-was reviewed from a point of view of pharmacokinetics. In case of bleomycin, according to its fast disappearance from blood, fast and significant excretion into urine, cell-cycle-dependent antitumor action, fast repair of potentially lethal damage, and pulmonary toxicity due to damage in endothelium of pulmonary capillary caused by high blood concentration of bleomycin, continuous intravenous administration seems to be a useful method to prevent pulmonary toxicity and to enhance antitumor effect. In case of adriamycin, according to its cardiotoxicity due to damage in cardiac muscle cell caused by high blood concentration on adriamycin, drip infusion or weekly low dose schedule is a safe, effective therapy to prevent cardiomyopathy. In case of aclacinomycin A, based on the mechanism of action of its marked inhibition in RNA synthesis compared to adriamycin, daily administration for certain days is an effective method.
Similar articles
-
[Continuous venous infusion in cancer chemotherapy].Gan To Kagaku Ryoho. 1985 Apr;12(4):798-805. Gan To Kagaku Ryoho. 1985. PMID: 2580486 Japanese.
-
Experimental and clinical studies on aclarubicin in the treatment of solid tumors.Biomed Pharmacother. 1984;38(7):332-7. Biomed Pharmacother. 1984. PMID: 6596963
-
Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.Int J Clin Pharmacol Ther Toxicol. 1982 Jan;20(1):12-8. Int J Clin Pharmacol Ther Toxicol. 1982. PMID: 6173340
-
Anthracycline dose intensity: clinical pharmacology and pharmacokinetics of high-dose doxorubicin administered as a 96-hour continuous intravenous infusion.J Infus Chemother. 1996 Spring;6(2):69-73. J Infus Chemother. 1996. PMID: 8809652 Review.
-
Dose optimization of anthracyclines.Anticancer Res. 1994 Nov-Dec;14(6A):2307-13. Anticancer Res. 1994. PMID: 7825964 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources